ALGN Quote, Financials, Valuation and Earnings

Envista Holdings has a net margin of 10.43% compared to Align Technology's net margin of 0.18%. Align Technology's return on equity of 11.12% beat Envista Holdings's return on equity of -32.33%.

Align Technology has a consensus price target of $225.04, signalling upside risk potential of 22.74%. On the other hand Envista Holdings has an analysts' consensus of $20.00 which suggests that it could grow by 25.47%. Given that Envista Holdings has higher upside potential than Align Technology, analysts believe Envista Holdings is more attractive than Align Technology.

Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Envista Holdings has a beta of 1.120, suggesting its more volatile than the S&P 500 by 12.044%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Envista Holdings offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Align Technology pays -- of its earnings as a dividend. Envista Holdings pays out -- of its earnings as a dividend.

Align Technology quarterly revenues are $995.2M, which are larger than Envista Holdings quarterly revenues of $652.9M. Align Technology's net income of $103.8M is higher than Envista Holdings's net income of $1.2M. Notably, Align Technology's price-to-earnings ratio is 32.68x while Envista Holdings's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.44x versus 1.10x for Envista Holdings. Usually stocks with elevated PS ratios are considered overvalued.

ResMed has a net margin of 10.43% compared to Align Technology's net margin of 28.26%. Align Technology's return on equity of 11.12% beat ResMed's return on equity of 25.76%.

Align Technology has a consensus price target of $225.04, signalling upside risk potential of 22.74%. On the other hand ResMed has an analysts' consensus of $263.15 which suggests that it could grow by 11.56%. Given that Align Technology has higher upside potential than ResMed, analysts believe Align Technology is more attractive than ResMed.

Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison ResMed has a beta of 0.755, suggesting its less volatile than the S&P 500 by 24.514%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. ResMed offers a yield of 0.88% to investors and pays a quarterly dividend of $0.53 per share. Align Technology pays -- of its earnings as a dividend. ResMed pays out 27.65% of its earnings as a dividend. ResMed's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Align Technology quarterly revenues are $995.2M, which are smaller than ResMed quarterly revenues of $1.3B. Align Technology's net income of $103.8M is lower than ResMed's net income of $365M. Notably, Align Technology's price-to-earnings ratio is 32.68x while ResMed's PE ratio is 26.47x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.44x versus 6.93x for ResMed. Usually stocks with elevated PS ratios are considered overvalued.

Steris PLC has a net margin of 10.43% compared to Align Technology's net margin of 12.66%. Align Technology's return on equity of 11.12% beat Steris PLC's return on equity of 7.27%.

Align Technology has a consensus price target of $225.04, signalling upside risk potential of 22.74%. On the other hand Steris PLC has an analysts' consensus of $250.11 which suggests that it could grow by 11.16%. Given that Align Technology has higher upside potential than Steris PLC, analysts believe Align Technology is more attractive than Steris PLC.

Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Steris PLC has a beta of 0.873, suggesting its less volatile than the S&P 500 by 12.657%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Steris PLC offers a yield of 0.99% to investors and pays a quarterly dividend of $0.57 per share. Align Technology pays -- of its earnings as a dividend. Steris PLC pays out 53.03% of its earnings as a dividend. Steris PLC's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

Align Technology quarterly revenues are $995.2M, which are smaller than Steris PLC quarterly revenues of $1.4B. Align Technology's net income of $103.8M is lower than Steris PLC's net income of $173.5M. Notably, Align Technology's price-to-earnings ratio is 32.68x while Steris PLC's PE ratio is 47.77x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.44x versus 4.14x for Steris PLC. Usually stocks with elevated PS ratios are considered overvalued.

Dentsply Sirona has a net margin of 10.43% compared to Align Technology's net margin of -47.51%. Align Technology's return on equity of 11.12% beat Dentsply Sirona's return on equity of -32.39%.

Align Technology has a consensus price target of $225.04, signalling upside risk potential of 22.74%. On the other hand Dentsply Sirona has an analysts' consensus of $18.43 which suggests that it could grow by 34.03%. Given that Dentsply Sirona has higher upside potential than Align Technology, analysts believe Dentsply Sirona is more attractive than Align Technology.

Align Technology has a beta of 1.728, which suggesting that the stock is 72.834% more volatile than S&P 500. In comparison Dentsply Sirona has a beta of 0.918, suggesting its less volatile than the S&P 500 by 8.232%.

Align Technology has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Dentsply Sirona offers a yield of 4.66% to investors and pays a quarterly dividend of $0.16 per share. Align Technology pays -- of its earnings as a dividend. Dentsply Sirona pays out -13.85% of its earnings as a dividend.

Align Technology quarterly revenues are $995.2M, which are larger than Dentsply Sirona quarterly revenues of $905M. Align Technology's net income of $103.8M is higher than Dentsply Sirona's net income of -$430M. Notably, Align Technology's price-to-earnings ratio is 32.68x while Dentsply Sirona's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Align Technology is 3.44x versus 0.74x for Dentsply Sirona. Usually stocks with elevated PS ratios are considered overvalued.